Business

Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New Director

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2020) - Genix Pharmaceuticals Co...

articleGenix Pharmaceuticals CorporationSeptember 22, 20203/company/genixpharmaceucticals-corporation/news/genix-pharmaceuticals-corporation-announces-agm-results-and-welcomes-new-director
Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New Director

About this update from Genix Pharmaceuticals Corporation

[{"type":"text","content":"Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New DirectorVancouver, British Columbia--(Newsfile Corp. - September 22, 2020) - Genix Pharmaceuticals Corporation (TSXV: GENX) (\"GENIX\" or the \"Company\") announces the results of its annual general meeting of shareholders (\"AGM\") held in Vancouver, British Columbia on September 18, 2020.Shareholders approved all the nominees listed in the management information circular (the \"Circular\"), which was mailed to GENIX shareholders of record as of August 17, 2020. The following were elected to the board of directors of the Company to hold office until the next annual meeting of shareholders or until their successors are duly appointed or elected.Sina Salehi PiroozKevin James Bottomley  Jamie LewinDarryl Yea GENIX is pleased to announce the addition of Darryl Yea to the Company's Board of Directors which was approved at the AGM. Mr. Yea is currently president of Investco Capital Management Inc., a private Vancouver-based company that invests in a diverse range of businesses and projects and advises on mergers and acquisitions, corporate and strategic issues. He was formerly chairman, president and chief executive officer of Toronto Stock Exchange-listed Datawest Solutions Inc., a banking technology and payment processing company, and president and CEO of a publicly listed national financial services organization. Mr. Yea was a former member of the board of governors of the Vancouver Stock Exchange, the predecessor to the TSX Venture Exchange, and chaired several of its committees. Formerly a member of the faculty advisory board of the Sauder School of Business at the University of British Columbia, Mr. Yea also served on the boards of several other public companies including chairing special board committees that oversaw privatizations and divestitures. Most recently he served as chairman and lead director of Apteryx Imaging Inc. (TSXV: XRAY) which was acquired in an all cash transaction in August 2020 by a US private equity firm. He holds a Bachelor of Commerce degree from the University of British Columbia in both Urban Land Economics and Finance, and was a member of the Real Estate Institute of British Columbia and of the Institute of Certified Management Consultants of British Columbia.In addition to the Nomination of the Directors for the ...

More updates from Genix Pharmaceuticals Corporation